FB deal puts it on course to be debt free next year; Reliance Retail biggest gainer from WhatsApp, JioMart arrangement
Galaxy Surfactants, SRF, Aarti Industries among companies to benefit given supply of essential ingredients, alternative supply chain to China and weak crude oil prices
Higher tractor margins, cash on books and better capital allocation policy are positives
With the pharma sector being rerated, given steady growth prospects and attractive valuations, all the companies, including pharma MNCs, will see greater investor interest
Weak exports and sluggish capex cycle suggest that there would be some near-term pain
The recent gains came on Monday after the company received the USFDA approval for its Nagpur facility
35% correction and long-term growth plans keep brokerages positive
Bookings at Rs 2,380 cr were twice that of the October-December period, 10% higher than year-ago quarter as firm used online sales heavily to post highest ever quarterly sales
Brokerages prefer Bajaj and Hero, given its weak financial profile and premium valuation
The pharma sector, once considered a safe bet, has been trailing the benchmark indices for four years in a row
The country accounts for 44% of overall revenues
While valuations are attractive, disruption will keep volumes muted
Analysts expect dent in near-term profits
Brokerages have cut their advertising and earnings estimates for broadcasters by up to 11 per cent
If the pandemic continues, a fifth of annual revenues could get affected
Higher share of replacement segment should help cushion demand drop
Motherson Sumi, Apollo Tyres and Tata Motors to be among the worst affected because of high exposure
Sharp fall in crude oil prices, however, is a positive
Hotel stocks are under pressure because the coronavirus outbreak could impact occupancies and, thus, drive down room tariffs
The development comes as passenger growth - which has been slowing down on account of the economic slowdown - has taken further hit due to the outbreak of coronavirus